Rapamycin Shows Promise for Cardiac Health in Elderly Adults
Small trial tests whether rapamycin, an FDA-approved drug, can improve heart function and immune response in people aged 70-95.
611 articles
Small trial tests whether rapamycin, an FDA-approved drug, can improve heart function and immune response in people aged 70-95.
Small study tests whether protein blends can help older adults maintain muscle mass and strength through improved protein synthesis.
Six-month trial examines whether metformin treatment can improve telomere length and longevity gene expression in prediabetic individuals.
144-person study explores how rapamycin, amino acids, and resistance exercise combat sarcopenia and muscle wasting in aging adults.
Small trial tests whether leucine supplementation enhances muscle-building effects of resistance exercise in frail elderly women.
FDA-approved transplant drug tested in 70-95 year olds to combat age-related immune decline and improve longevity markers.
Greek researchers investigated whether whey protein can counter inflammation-driven muscle loss in older adults with chronic inflammation.
McMaster study compares whole milk, skim milk, and almond beverage effects on muscle protein synthesis in aging women.
60-patient trial explores whether metformin, combined with standard therapy, could slow Parkinson's progression through metabolic pathways.
New study reveals metformin's anti-aging effects depend entirely on whether you're insulin resistant or sensitive.
VA study tests whether combining lifestyle changes with metformin can reverse muscle loss and frailty in obese older adults.
Clinical trial tested whether metformin could enhance resistance training benefits for muscle mass and strength in older adults.